|
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG
/ Key word(s): Miscellaneous
Berlin, 24 March 2023. The Executive Board and Supervisory Board of Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) have decided to prepare the conversion of the company into a European Company (Societas Europaea, SE) by changing its legal form. The dualistic management system, consisting of an Executive Board as the management body and a Supervisory Board as the supervisory body, is also to continue under the SE legal form. Responsibilities and composition of the executive board and supervisory board remain unaffected by the new structure. The registered office of the company shall continue to be in Berlin. The shareholders of Eckert & Ziegler AG will resolve on the measure at the upcoming Annual General Meeting, which is expected to take place on 7 June 2023 in Berlin. The effectiveness of the conversion into the legal form of an SE also requires that the procedure for the agreement on the involvement of employees in the future Eckert & Ziegler SE is completed or terminated before registration. "With the change of legal form, we want to underline Eckert & Ziegler's positioning as a future-oriented international healthcare company," explains Dr Harald Hasselmann, member of the Executive Board of Eckert & Ziegler AG. The SE conversion will fundamentally not affect the legal position of the shareholders of Eckert & Ziegler AG. Shareholders will hold the same number of no-par-value shares in Eckert & Ziegler SE. The listing of EZAG shares in the Prime Standard of the Frankfurt Stock Exchange will also remain unaffected by the change of legal form, so that the shares of the future Eckert & Ziegler SE will continue to have the previous ISIN DE0005659700 and WKN 565970. About Eckert & Ziegler.
24.03.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | +49 30 941084-138 |
| Fax: | +49 30 941084-112 |
| E-mail: | karolin.riehle@ezag.de |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1592223 |
| End of News | EQS News Service |
|
|
1592223 24.03.2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
